This correction is made in compliance with Section 39n(3) of the Act and becomes effective on the day it is published on the official notice board. The List’s correction lays down the full list of medicinal products (MPs) and foods for special medicinal purposes (FSMPs) reimbursed from the public health insurance system subject to the Institute’s decision, including their maximum or announced ex-factory prices, the amount and the terms of reimbursement, incl. their highest possible reimbursement for the end consumer, along with the amount of the extra payment in the eligible limit. In addition, the List contains the basic reimbursements of reference groups and explains the reasoning behind the basic reimbursements, along with a full list of the medicinal products and foods for special medicinal purposes included in the reference groups.
In the published correction, the Institute has taken into account the change in the marketing authorisation status of the medicinal product Olysio, 150MG CPS DUR 28, SÚKL code 210009, because the withdrawal of the marketing authorisation for this medicinal product should be effective from 1. 5. 2018.
List of prices of medicinal products and fedical purposes